Protocol Ledger

NCT06347159 · Phase II · ACTIVE NOT RECRUITING

A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)

Interventional Phase II clinical trial protocol NCT06347159 sponsored by Edgewise Therapeutics in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-04-11 Enrollment: 79 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06347159
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)79 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06347159
Protocol FieldVerified Registry Value
NCT IdentifierNCT06347159
Consolidated Lead SponsorEdgewise Therapeutics
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase II
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment79 participants (ESTIMATED)
Registered Start Date2024-04-11
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI